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TissuesProteomics analysis is important for characterizing tissues to gain biological and pathological insights,
which could lead to the identiﬁcation of disease-associated proteins for disease diagnostics or targeted
therapy. However, tissues are commonly embedded in optimal cutting temperature medium (OCT) or
are formalin-ﬁxed and parafﬁn-embedded (FFPE) in order to maintain tissue morphology for histology
evaluation. Although several tissue proteomic analyses have been performed on FFPE tissues using
advanced mass spectrometry (MS) technologies, high-throughput proteomic analysis of OCT-embedded
tissues has been difﬁcult due to the interference of OCT in the MS analysis. In addition, molecules other
than proteins present in tissues further complicate tissue proteomic analysis. Here, we report the
development of a method using chemical immobilization of proteins for peptide extraction (CIPPE). In
this method, proteins are chemically immobilized onto a solid support; interferences from tissues and
OCT embedding are removed by extensive washing of proteins conjugated on the solid support. Peptides
are then released from the solid phase by proteolysis, enabling MS analysis. This method was ﬁrst vali-
dated by eliminating OCT interference from a standard protein, human serum albumin, where all of the
unique peaks contributed by OCT contamination were eradicated. Finally, this method was applied for
the proteomic analysis of frozen and OCT-embedded tissues using iTRAQ (isobaric tag for relative and
absolute quantitation) labeling and two-dimensional liquid chromatography tandem mass spectrometry.
The data showed reproducible extraction and quantitation of 10,284 proteins from 3996 protein groups
and a minimal impact of OCT embedding on the analysis of the global proteome of the stored tissue
samples.






proteinsTissue proteins play important roles in biological processes. The
quantitative analysis of tissue proteins facilitates the understand-
ing of molecular mechanisms that differentiate between normal
and disease states. Disease-speciﬁc tissue-derived proteins can
also be used as biomarkers for disease diagnosis or as novel drug
targets for therapeutic drug development [1]. In the diseased state,
tissues secrete or shed disease-speciﬁc proteins into the body ﬂu-
ids such as serum, which can be used as biomarkers. However, the
secreted proteins from a diseased tissue are present in higher con-
centrations at the tissue site and become diluted in the serum,
which contains proteins from other tissues [1,2]. If disease-speciﬁc
proteins can be identiﬁed in tissues, tissue-targeted approaches
can be used to detect tissue-derived proteins in serum [1]. An
example of this type of approach was shown for the detection ofprostate cancer proteins in serum using tandem time-of-ﬂight
(TOF/TOF)1 mass spectrometry (MS) [3].
Traditionally, tissue proteins are analyzed using immunoassays,
which rely on the development of high-quality antibodies.
Advances in MS and high-performance liquid chromatography
(HPLC) systems have led to the increasingly widespread applicabil-
ity of proteomics [4]. Increases in sensitivity, resolution, and speedd saline;
romatog-
te; PTM,
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large numbers of proteins with high conﬁdence, thereby enabling
the analysis of complex samples such as tissue. Analysis of the tis-
sue proteome, located at the primary site of pathology, aids the
understanding of the molecular mechanism of diseases and facili-
tates the identiﬁcation of potential biomarkers and therapeutic
targets.
Tissue proteomics requires tissues to be stored by snap-freez-
ing. However, ﬂash-frozen tissues without embedding medium
are difﬁcult to section, thereby making histopathology or immuno-
histochemistry evaluation difﬁcult. Instead, tissues are embedded
in optimal cutting temperature medium (OCT) or are formalin-
ﬁxed and parafﬁn-embedded (FFPE) to retain their morphology
[5]. Recently, proteomic analyses have been performed on FFPE-
embedded tissues [6–8]. However, FFPE tissues undergo extensive
protein/DNA/RNA cross-linking during formalin ﬁxation, which
creates inter- and intra-cross-linked proteins [5,9,10]. Some of
the peptide modiﬁcations that occur in the proteomic analysis of
FFPE tissues are methylol derivatives, Schiff bases, and methylene
bridges [9]. The duration of FFPE processing and storage can also
lead to different levels of protein degradation and protein modiﬁ-
cations. In contrast, OCT-embedded tissues are instantly frozen
and stored for histological studies; therefore, the protein content
likely remains unchanged and is representative of the tissue
proteome.
OCT is widely used for tissue embedding prior to storage.
However, the proteomic analysis of OCT-embedded tissues is
difﬁcult, largely due to the presence of water-soluble synthetic
polymers. OCT can compete with peptides for ionization during
MS analysis [11]. OCT can also generate ion suppression in
matrix-assisted laser desorption/ionization (MALDI) MS and ioni-
zation competition in electrospray ionization (ESI) MS [12]. In
addition, OCT creates a deleterious effect on the peptide chromato-
graphic separation required for tissue proteomics. OCT has a high
afﬁnity to the reversed-phase stationary medium commonly used
in shotgun proteomics. OCT competes with peptides for binding
to the C18 reversed-phase column. OCT also decreases the sensitiv-
ity of detection due to its propensity to coelute with peptides dur-
ing chromatographic separation. Thus, it is necessary to remove
OCT prior to the liquid chromatography–tandem mass spectrome-
try (LC–MS/MS) analysis of tissues.
Due to the malicious effect of OCT on the mass spectrometer,
only a small number of proteomic studies have been performed
on OCT-embedded tissues [13–17]. OCT-embedded tissues are
studied using either two-dimensional gel electrophoresis (2D
DIGE) technology or shotgun proteomics using LC–MS/MS. 2D
DIGE can separate proteins from OCT; however, most of the LC–
MS/MS studies of OCT-embedded tissue did not completely
remove OCT, resulting in fewer protein identiﬁcations [15–17].
Recently, we demonstrated that OCT-embedded tissues could be
used for glycoproteomic analysis using solid-phase extraction of
glycopeptides (SPEG) [18]. The glycopeptides were chemically
immobilized to the solid support using oxidized glycan tags,
whereas the non-glycopeptides and OCT were removed from the
immobilized peptides before the enzymatic release of N-glycopep-
tides. Whereas the SPEG method was used to effectively remove
the OCT interference prior to glycoprotein analysis, proteins with-
out glycans were not conjugated to the solid phase and were
excluded from the proteomic analysis.
In this study, we describe a method using chemical immobiliza-
tion of proteins for peptide extraction (CIPPE) from tissues for tis-
sue proteomic analysis. In this method, proteins are chemically
immobilized onto a solid support, which allows for sample clean-
ing to remove interferences from tissues before peptides are
released from the solid support using proteolysis. We applied the
method to the quantitative analysis of frozen and OCT-embeddedtissues to determine the impact of OCT on the MS-based detection
of the tissue proteome.Materials and methods
Materials
Human serum albumin (HSA), 1 PBS (phosphate-buffered
saline) buffer, dithiothreitol (DTT), sodium cyanoborohydride,
and iodoacetamide were purchased from Sigma–Aldrich (St. Louis,
MO, USA). A protein estimation BCA (bisinchoninic acid) kit, poly-
acrylamide desalting spin columns, and AminoLink coupling resin
were purchased from Thermo Scientiﬁc (Rockford, IL, USA).
Sequencing-grade trypsin was purchased from Promega (Madison,
WI, USA). iTRAQ 4-plex reagents were purchased from AB Sciex
(Framingham, MA, USA). PNGase F was obtained from New
England Biolabs (Ipswich, MA, USA).Protein extraction
Mouse kidney tissue was collected from NIH01a mice and snap-
frozen in Christopher Kemp’s laboratory at the Fred Hutchinson
Cancer Research Center [19,20]. Mouse kidney tissue was cut in
half. One half was embedded in OCT, followed by storage at
80 C. The other half was stored as fresh-frozen tissue. The
OCT-embedded or frozen mouse kidney tissue was lysed in 1 ml
of RIPA buffer (100 mM sodium citrate, 50 mM sodium carbonate,
and 1% NP-40) by vortexing for 2 to 3 min and sonicating for 4 min
in an ice bath to homogenize the tissues. After the tissues were
homogenized, the buffer of the extracted proteins was exchanged
with 1 ml of pH 10 binding solution (40 mM sodium citrate and
20 mM sodium carbonate) using polyacrylamide desalting spin
columns. The protein concentration was determined by BCA assay.
Protein (1 mg) from each tissue was used for AminoLink resin
capture using the chemical immobilization of proteins to beads
protocol as described previously [21,22]. Brieﬂy, AminoLink resin
(800 ll) was loaded onto snap-cap spin columns and centrifuged
at 2000g for 1 min. Resin was washed with 800 ll of pH 10 buffer
(100 mM sodium citrate and 50 mM sodium carbonate), followed
by centrifugation. The wash step was repeated twice. The sample
in pH 10 buffer (1 mg:200 ll, protein/beads) was added to the
washed AminoLink resin.
The sample–resin mixture was incubated at room temperature
overnight on a mixer. The mixture was centrifuged at 2000g to
remove any unbound protein. The resin was rinsed three times
with 450 ll of 1 PBS buffer. Then, 50 mM sodium cyanoborohy-
dride in PBS (400 ll) was added to the resin. After a 4-h incubation,
the supernatant was removed via centrifugation (2000g), and
400 ll of 1 M Tris–HCl (pH 7.6) in the presence of 50 mM sodium
cyanoborohydride was added to block any unreacted aldehyde
sites on the resin. The blocking process was terminated after 1 h.
Then, the beads were washed twice with 1 PBS, twice with
1.5 M NaCl, and three times with deionized water.Peptide extraction by proteolysis
Proteins bound to the beads were treated with 10 mM DTT in
50 mM ammonium bicarbonate for 30 min at 60 C, followed by
a wash with 50 mM ammonium bicarbonate. Afterward, the beads
were treated for 1 h with 15 mM iodoacetamide in 50 mM ammo-
nium bicarbonate in the dark. Finally, proteins were digested using
trypsin (1:50, enzyme/substrate) in the presence of 50 mM ammo-
nium bicarbonate. The proteins were digested at 37 C overnight.
The released peptides were collected from the supernatant of the
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ing was performed according to the manufacturer’s protocol [23].
In-solution digestion
HSA protein with and without OCT was incubated with 10 mM
DTT at 60 C for 1 h and alkylated for 30 min with 10 mM iodoacet-
amide in the dark at room temperature. The pH of the solution was
adjusted to 7.5 with 50 mM NH4HCO3, and protein was enzymati-
cally digested with trypsin (1:50, enzyme/substrate) with over-
night incubation at 37 C.
MS analysis of peptides by direct infusion to TSQ Quantum
A TSQ Quantum Ultra triple quadrupole mass spectrometer
(Thermo Scientiﬁc) with an ESI source was used for the analysis
of HSA peptides using direct infusion. The ﬂow rate was set at
5 ll/min. Peptides were scanned from m/z 300 to 1000 using a
spray voltage of 3000 V and a capillary temperature of 180 C.
High-pH RPLC fractionation
iTRAQ-labeled peptides (200 lg) were subjected to high-pH
RPLC (reversed-phase liquid chromatography) fractionation with
a 1200 Inﬁnity LC system (Agilent Technology, Santa Clara, CA,
USA) and a 4.6  100-mm BEH130 C18 column (Waters, Milford,
MA, USA). Samples were adjusted to a basic pH using 1% ammo-
nium hydroxide and injected into 2 ml of solvent A (7 mM triethyl
ammonium bicarbonate [TEAB] in water). Solvent B was 7 mM
TEAB in 90% acetonitrile.
The separation gradient was set as follows: 0% B in 18 min, 0 to
31% B in 42 min, 31 to 50% B in 10 min, 75 to 100% B in 15 min, and
100% B in an additional 10 min. A total of 96 fractions were col-
lected throughout the LC separation and were concatenated into
24 fractions according to the following scheme: fractions 1, 25,
49, and 73; fractions 2, 26, 50, and 74, and so forth. The samples
were dried in a SpeedVac and stored at 80 C until LC–MS/MS
analysis.
LC–MS/MS analysis
A Dionex Ultimate 3000 RSLC nano system (Thermo Scientiﬁc)
was used with a 75 lm  25-cm Acclaim PepMap100 separating
column (Thermo Scientiﬁc). Peptides were separated using a ﬂow
rate of 300 nl/min with mobile phases A (0.1% formic acid in water)
and B (0.1% formic acid in 95% acetonitrile). The gradient proﬁle
was set as follows: 4 to 35% B in 70 min and 35 to 95% B in
5 min. MS analysis was performed using a Q Exactive mass spec-
trometer (Thermo Scientiﬁc). The spray voltage was set at 2.0 kV.
Orbitrap spectra were collected at a resolution of 70 K followed
by data-dependent HCD (higher energy collisional dissociation)
MS/MS (at a resolution of 17,500 and collision energy of 33) of
the 20 most abundant ions. A dynamic exclusion time of 25 s
was used.
Database search
Data generated using Orbitrap were searched using SEQUEST
with Proteome Discoverer 1.3 (Thermo Scientiﬁc) against the IPI
mouse version 3.87 database containing 59,534 protein entries.
Peptides were searched with fully tryptic speciﬁcity allowing only
two missed cleavages. The search parameters used were 10 ppm
precursor tolerance and 0.06 Da fragment ion tolerance, a static
modiﬁcation of 4-plex iTRAQ at the N terminus, and carbamidome-
thylation of cysteine. The following variable modiﬁcations were
used: oxidation of methionine, deamidation of asparagine, and4-plex iTRAQ modiﬁcation of lysine. Filters used for data analysis
included peptide rank 1, 2 peptides per protein, and 2% FDR (false
discovery rate) threshold.Data analysis
Peaks were selected from ESI spectra acquired on a TSQ
Quantum mass spectrometer with a threshold of 20% intensity of
the base peak intensity. Peaks were obtained from HSA protein
digested in the presence of OCT, without OCT, and with OCT fol-
lowed by the removal of OCT. Afterward, the spectra were aligned
and compared. The comparison was performed among HSA, HSA
with OCT, and HSA with OCT followed by OCT removal using CIPPE.
The Pearson’s correlation coefﬁcient of the peptide spectra
obtained between replicate analyses of OCT-embedded tissues
(iTRAQ 116 and 117) and frozen tissue (iTRAQ 114 and 115) using
CIPPE was calculated to assess the reproducibility of the OCT
removal method. Protein expression from the OCT-embedded tis-
sue (116 and 117) and frozen tissue (114 and 115) was quantiﬁed
and normalized using Proteome Discoverer 1.3. The log2 ratios
between replicates 116 and 117 were used as the ‘‘null’’ distribu-
tion, and the values for the 5% cutoff (2.5th and 97.5th percentiles)
of the histogram were selected as the thresholds for increased and
decreased expression. Similarly, the Pearson’s correlation coefﬁ-
cient of the peptide spectra between the OCT-embedded tissues/
frozen tissues (116/114 and 117/115) was calculated to assess
the impact of embedding the tissue in OCT.Results and discussion
To analyze the global proteome of tissues, therefore, we
employed the CIPPE method based on the capture of proteins by
conjugation of amino groups of proteins to beads containing alde-
hyde groups (Fig. 1). After washing, the proteins conjugated to
beads were reduced, carbamidomethylated, and proteolyzed to
release the peptides for proteomic analysis (Fig. 1). Using this
method, proteins were extracted from tissues and chemically
immobilized onto the solid phase by reductive amination, and pep-
tides were released from solid phase by proteolytic digestion.
However, OCT polymers from OCT-embedding and other MS inter-
fering molecules from tissues were not immobilized on the beads
or not released from beads. Therefore, they were removed by
washing the beads.
To develop a procedure to remove the OCT, HSA was used as a
model protein. The tryptic peptides from HSA with OCT contami-
nation were directly analyzed by a TSQ Quantum mass spectrom-
eter using direct infusion ESI. Fig. 2A shows the ESI spectrum of
OCT-contaminated HSA digested with trypsin demonstrating an
MS pattern with a regular bell-shaped curve with mass values that
are 44, 22, and 14.6 Da apart. These readily observed peaks corre-
spond to different charge states of the polyethylene glycol present
in OCT. The OCT polymer peaks mask those of the HSA peptides. In
MS, OCT dominates the mass spectrum, indicating the preferential
ionization of OCT compared with the HSA peptides in a set mixture
of OCT to the HSA peptide. At 20% of the base peak intensity, only
11 peptide HSA peaks were detected in the OCT-contaminated HSA
(10% OCT volume/HSA weight) (Fig. 2A). In contrast, OCT-contam-
inated HSA had 46 unique polymer peaks that suppressed the ion-
ization of HSA peptides and overshadowed these peptides in the
mass spectrum. To remove OCT interferences from the sample, ﬁrst
OCT-contaminated HSA was chemically immobilized onto beads
using reductive amination, then the beads were then washed with
various conditions, and ﬁnally the immobilized HSA was digested
using trypsin. The released peptides were analyzed (Fig. 2B). We
found that after washing the beads with PBS, 1.5 M NaCl, and
Fig.1. Scheme for chemical immobilization of proteins for peptide extraction
(CIPPE). Proteins are conjugated onto the solid support. Unbound compounds are
washed away. Peptides are released from the solid support using proteolysis and
are analyzed using LC–MS/MS.
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peaks were visible in the mass spectra. None of the 46 polymer
peaks uniquely observed in the OCT sample was observed after
CIPPE. In this method, proteins were bound to the solid phase
and released by trypsin. The OCT polymers were removed
from released HSA tryptic peptides, resulting in the complete
removal of OCT from chemically immobilized proteins. The results
showed that CIPPE removed OCT contaminants from the protein
sample, thereby enabling the MS analysis of proteins with OCT
contamination.
CIPPE is a chemical immobilization method for protein immobi-
lization via protein amino groups and peptide release by protease
digestion. To compare the peptide spectral pattern from protein
directly digested by trypsin in solution and the peptide spectral
pattern released from immobilized protein, HSA without OCT con-
tamination was digested in solution. The tryptic peptides from HSA
digested in solution were directly analyzed by a TSQ Quantum
mass spectrometer using direct infusion ESI, and the peptides were
compared with the tryptic peptides from the HSA digested on
beads. The spectrum of HSA tryptic peptides digested in solution
showed that the mass ﬁngerprint of the albumin tryptic peptides
differed between CIPPE (Fig. 2B) and the in-solution digestion of
HSA (Fig. 2C). The difference may have resulted from the OCT con-
tamination of HSA or the sample process using CIPPE. To determine
whether peptides, especially the Lys-containing peptides, were lost
due to the conjugation of protein to solid phase using CIPPE, the
peptide samples from the CIPPE method and the in-solution diges-
tion were analyzed by LC–MS/MS using a Q Exactive mass
spectrometer. The same amount of HSA peptides prepared from
the two methods was analyzed in triplicate LC–MS/MS runs (see
Supplemental Table 1 in online supplementary material). Overall,
94 peptides were identiﬁed in all six LC–MS/MS runs, 10 peptideswere only identiﬁed from the peptides prepared using the CIPPE
method and 9 of them were Lys-containing peptides, and 10 pep-
tides were only identiﬁed from the in-solution digestion and all
of them were Lys-containing peptides (Supplemental Table 1).
The peptide spectral counts of HSA from the two methods were
also used for relative quantitation (Supplemental Table 1). We
identiﬁed the 74 common peptides from the in-solution digestion
and the on-bead digestion using the CIPPE method but with differ-
ent spectral counts. The spectral counts of 10 peptides (9 Lys-con-
taining peptides) were reduced at least 2-fold in the in-solution
digested sample compared with the on-bead digested sample.
The spectral counts of 18 peptides (14 Lys-containing peptides)
were increased at least 2-fold in the in-solution digested peptides
compared with the on-bead digested sample.
The results show that there are no signiﬁcant losses of Lys-
containing peptides from the on-bead digested samples using the
CIPPE method. However, peptides prepared from on-bead diges-
tion using the CIPPE method and in-solution digestion showed
different patterns (Fig. 2). This could be due to the fact that protein
amino groups are randomly conjugated to the solid support and
conjugated peptides could be lost in abundance, but the Lys-con-
taining peptides are still detectable and identiﬁed due to random
conjugation on beads. In the CIPPE method, the proteolytic diges-
tion of proteins will not release chemically immobilized amino ter-
minal or Lys-containing peptides. However, proteins might not be
immobilized onto the beads at the same amino group-containing
peptides. Our data show that identiﬁcation of most of the peptides
on the immobilized protein is possible provided that there are var-
ious amino groups present in the protein. In a complex sample ana-
lyzed via a shotgun proteomic approach, commonly only two
peptides are required for protein identiﬁcation. In addition, prote-
ase digestion efﬁciency could differ between on-bead digestion
and in-solution digestion based on the availability of different pro-
tease digestion sites, which could result in the altered quantitation
of different peptides between on-bead digestion and in-solution
digestion. However, this random conjugation of amino group-con-
taining peptides and changes in protease digestion efﬁciency will
not affect the relative quantitation among the protein samples
because different protein samples are expected to have similar
conjugation and protease digestion efﬁciency.
To determine the impact of embedding tissue with OCT prior to
tissue proteomic analysis, we applied the developed method to
OCT-embedded tissues and frozen tissues. A complex biological tis-
sue, mouse kidney, was analyzed. Mouse kidney tissue was divided
into two halves. One half was embedded in OCT, and the other half
was directly frozen. An equal amount of protein from the four tis-
sues (1 mg) was used for quantitative proteomic proﬁling using
chemical immobilization and iTRAQ methodology (Fig. 3). Protein
from each sample was ﬁrst bound to beads. The quantity of
unbound protein was determined by BCA assay and was estimated
to be less than 5% of the protein input for protein immobilization.
Beads containing sample were rigorously washed. Proteins were
further reduced and alkylated on the beads. Finally, proteins were
released from the beads using proteolysis, and all of the released
peptides were iTRAQ labeled and mixed. Technical replicates of
an OCT-embedded tissue (labeled with iTRAQ 116 and 117) and
technical replicates of a frozen tissue (labeled with iTRAQ 114
and 115) were lysed. Here, 200 lg of sample was used for global
proteomic analysis. In the global proteomic analysis, basic RPLC
was used to generate 24 ofﬂine fractions, and each fraction was
subjected to LC–MS/MS analysis using a Q Exactive mass spectrom-
eter (Fig. 3).
From the proteomic analysis of the iTRAQ-labeled tryptic
peptides, 10,284 proteins belonging to 3996 protein groups were
identiﬁed on the basis of at least two unique peptides exceeding
a threshold score of 2% FDR (see Supplemental Table 2 in supple-
Fig.2. MS detection of the tryptic peptides from HSA with and without OCT. (A) A representative ESI spectrum of the tryptic peptides from OCT-contaminated HSA digested in
solution. (B) A representative ESI spectrum of OCT-contaminated HSA after OCT removal using CIPPE. (C) A representative ESI spectrum of clean HSA digested in solution.
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Each dot represents an identiﬁed peptide. The replicates of 114/
115 and 116/117 showed little variance. The correlation between
channels 116 and 117 was 0.990 for the replicate global proteomic
analysis of OCT-embedded tissues. Similarly, the correlation
between iTRAQ channels 114 and 115 was 0.996 for the replicate
proteomic analysis of frozen tissues. From the analysis of replicate
OCT-embedded tissues using CIPPE and MS/MS, we estimated that
95% of proteins had a ratio between 0.850 and 1.180, which indi-
cated good analytical reproducibility of the frozen and OCT-
embedded tissues using the CIPPE method based on the chemical
immobilization of tissue proteins. Our results showed that accurate
quantitation could be achieved on OCT-embedded tissues and fro-
zen tissues using chemical immobilization, iTRAQ labeling, and
MS/MS.
To determine the impact of OCT embedding on tissue
proteomics, we further analyzed the quantitative data from the
OCT-embedded tissues and compared them with the data from
the frozen tissues. The scatter plot of intensities of the iTRAQ chan-
nels 116 versus 114 and 117 versus 115 (OCT-embedded tissue vs.
frozen tissue) showed similar patterns as the technical replicates ofthe OCT-embedded tissues (Fig. 4). The quantitative distribution is
roughly symmetrical, with only a minimal spread from the R2 = 1
line in the scatter plot, indicating high quantitative similarity
between the frozen and OCT-embedded tissues. A vast majority
of the proteins from OCT-embedded tissue versus frozen tissue
showed a 1:1 ratio, with 91.0% (117/115) and 82.6% (116/114) of
the proteins exhibiting a ratio within the 0.850 to 1.180 cutoff
determined from the replicate analysis of OCT-embedded tissues.
The correlation of 0.923 between 114 and 116 and of 0.956
between 115 and 117 is similar to the replicate analysis of the
OCT-embedded tissues. The data showed that there were no signif-
icant differences between the OCT-embedded and frozen tissues.
Our results demonstrate that quantitative proteomic analysis of
OCT-embedded tissue is feasible using CIPPE. Using this method,
we successfully removed the interference from OCT and identiﬁed
thousands of tissue proteins from OCT-embedded tissues. CIPPE
has the potential to be used for PTM (post-translational modiﬁca-
tion) analysis such as glycosylation, phosphorylation, ubiquitina-
tion, and acetylation.
In addition to the removal of OCT from OCT-embedded tissues,
this method could be used to extract peptides from tissue proteins
Fig.3. Schematic diagram for the relative quantitation method used to study the
impact of OCT on tissue samples using the CIPPE method. Mouse kidney was split in
half. One half was embedded in OCT, and the second half was directly frozen at
80 C. Proteins were extracted from the two OCT-embedded tissues and the two
frozen tissues using CIPPE. Peptides were labeled with iTRAQ tags, and the labeled
peptides were combined. The iTRAQ-labeled tryptic peptides were analyzed using
2D LC–MS/MS.
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ids, the proteins from tissues are more difﬁcult to extract in order
to obtain a complete proteome due to the three-dimensional struc-
tures of tissues and solubility of certain tissue proteins. During the
proteomic analysis of tissues, detergents such as sodium dodecylFig.4. Quantitative analysis of proteins isolated from tissues using CIPPE. The scatter plo
115 and 117 (D). The 116 and 117 channels were used for the quantitative analysis of t
114:115, 116:117, 114:116, and 115:117 iTRAQ channels are plotted on the x axis and y
quantitative linearity between reporter ion groups. The sample and the reporter ion
distribution of fold change across the scatter plot.sulfate, NP-40, and Triton X-100 are often used to solubilize the
membrane proteins from tissues for protein extraction (NP-40
was included in the RIPA buffer to extract kidney tissue proteins
in this study). However, detergents also impede the MS detection
of peptides, similar to the spectra from the OCT-contaminated
HSA (Fig. 2A). In addition, these detergents, similar to OCT, bind
to reversed-phase columns that are commonly used online with
mass spectrometers, further impairing the capability of tissue pro-
teomics using LC–MS–MS/MS. The CIPPE method described here is
also capable of removing detergents from the tissue samples that
were introduced during the protein extraction for proteomic
analysis.
One of the limitations of this method is the incomplete release
of all tryptic peptides from the beads. After the proteins are chem-
ically immobilized onto the beads and washed, peptides are then
released from the beads using trypsin digestion. We have shown
that for protein identiﬁcation and quantiﬁcation, it is not necessary
to recover all tryptic peptides. However, in the cases where all
tryptic peptides are required for proteomic analysis, a cleavable
linker to the solid phase could be used to capture and release all
peptides. Another limitation of the current method is using the
same amino group of the Lys residue for protein capture and the
relative quantitation. The captured Lys residues are not cleaved
by trypsin and so are blocked for labeling reagents such as iTRAQ.
This will cause reduced quantity of Lys-containing peptides. How-
ever, the relative quantitation of the Lys-containing peptides from
different samples still remains quantitative given the fact that Lys
residues from each sample have similar coupling efﬁciency. For
absolute quantitation of speciﬁc Lys-containing peptides, other
amino acid residues such as cysteine can be used for coupling of
the proteins.t represents iTRAQ channels 115 and 114 (A), 116 and 117 (B), 114 and 116 (C), and
wo OCT-embedded tissues using CIPPE. The intensities observed for peptides in the
axis, respectively, for each peptide spectrum match. The scatter plot represents the
intensity scatter plot are clustered around a 45 line, indicating the symmetric
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This study shows that tissue proteins can be analyzed using
shotgun proteomics incorporating CIPPE and MS/MS. The CIPPE
methodology described here was used to conduct global proteomic
analyses of OCT-embedded tissues and frozen tissues. This method
is highly efﬁcient in the removal of contaminants and other mole-
cules and in the extraction of peptides for shotgun proteomics
using MS. Our data indicate that OCT does not appear to affect
the tissue proteome. Therefore, CIPPE can be used for the proteo-
mic and PTM analysis of OCT-embedded tissues, leading to the pos-
sibility of the tissue proteomics of OCT-embedded tissues.
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